OCGN OCUGEN INC revenue, earnings and financials
For the quarter ended June 30, 2026, OCUGEN INC reported revenue of $1.49M (up 8.4% from a year earlier), net income of −$24.9M and diluted EPS of −$0.07; over the last four quarters revenue was $4.58M and net income −$82.0M; for the fiscal year ended December 2025 revenue was $4.41M, up 8.8% on the year before.
OCGN annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $4.41M, gross profit n/a, operating income −$62.9M, net income −$68.0M (margin -1540.9%), EPS n/a
- Fiscal year ended Dec 2024: revenue $4.06M, gross profit n/a, operating income −$54.8M, net income −$54.0M (margin -1331.7%), EPS n/a
- Fiscal year ended Dec 2023: revenue $6.04M, gross profit n/a, operating income −$65.5M, net income −$63.0M (margin -1043.7%), EPS −$0.26
- Fiscal year ended Dec 2022: revenue $2.49M, gross profit n/a, operating income −$89.1M, net income −$86.8M (margin -3488.9%), EPS −$0.40
- Fiscal year ended Dec 2021: revenue $0, gross profit n/a, operating income −$58.0M, net income −$58.4M (margin n/a), EPS −$0.30
OCGN quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.49M (up 8.4% year over year), net income −$24.9M, EPS −$0.07
- Quarter ended Mar 31, 2026: revenue $1.53M (up 3.5% year over year), net income −$19.2M, EPS −$0.06
- Quarter ended Dec 31, 2025 (from the annual report): revenue −$193K (down 125.3% year over year), net income −$17.9M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $1.75M (up 54.2% year over year), net income −$20.1M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $1.37M (up 20.3% year over year), net income −$14.7M, EPS −$0.05
- Quarter ended Mar 31, 2025: revenue $1.48M (up 46.1% year over year), net income −$15.4M, EPS −$0.05
- Quarter ended Dec 31, 2024 (from the annual report): revenue $764K (down 45.8% year over year), net income −$13.8M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $1.14M (down 69.3% year over year), net income −$13.0M, EPS n/a
- Quarter ended Jun 30, 2024: revenue $1.14M (up 135.3% year over year), net income −$15.3M, EPS −$0.04
- Quarter ended Mar 31, 2024: revenue $1.01M (up 128.9% year over year), net income −$11.9M, EPS −$0.05
- Quarter ended Dec 31, 2023 (from the annual report): revenue $1.41M (up 60.3% year over year), net income −$10.9M, EPS −$0.03
- Quarter ended Sep 30, 2023: revenue $3.70M (up 693.8% year over year), net income −$11.7M, EPS −$0.05
- Quarter ended Jun 30, 2023: revenue $485K (down 24.6% year over year), net income −$23.1M, EPS −$0.10
- Quarter ended Mar 31, 2023: revenue $443K (down 11.4% year over year), net income −$17.3M, EPS −$0.08
- Quarter ended Dec 31, 2022 (from the annual report): revenue $879K, net income −$22.4M, EPS −$0.10
- Quarter ended Sep 30, 2022: revenue $466K, net income −$23.9M, EPS −$0.11
- Quarter ended Jun 30, 2022: revenue $643K, net income −$21.5M, EPS −$0.10
- Quarter ended Mar 31, 2022: revenue $500K, net income −$19.0M, EPS −$0.09
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$14.6M, EPS −$0.08
- Quarter ended Sep 30, 2021: revenue $0, net income −$10.8M, EPS −$0.05
OCGN cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$57.0M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$42.1M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$62.1M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$60.1M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$47.9M, share buybacks $0
OCGN balance sheet
- Jun 30, 2026: cash $100M, total assets $124M, total liabilities $141M, shareholders' equity −$16.6M, long-term debt $1.73M
- Mar 31, 2026: cash $31.9M, total assets $56.9M, total liabilities $51.1M, shareholders' equity $5.81M, long-term debt $24.2M
- Dec 31, 2025: cash $18.6M, total assets $43.5M, total liabilities $55.7M, shareholders' equity −$12.2M, long-term debt $27.5M
- Sep 30, 2025: cash n/a, total assets $57.6M, total liabilities $54.1M, shareholders' equity $3.53M, long-term debt $28.4M
- Jun 30, 2025: cash $27.0M, total assets $53.6M, total liabilities $50.5M, shareholders' equity $3.05M, long-term debt $28.0M
- Mar 31, 2025: cash $37.8M, total assets $64.5M, total liabilities $48.5M, shareholders' equity $15.9M, long-term debt $27.7M
- Dec 31, 2024: cash n/a, total assets $82.4M, total liabilities $52.8M, shareholders' equity $29.6M, long-term debt $27.3M
- Sep 30, 2024: cash n/a, total assets $61.9M, total liabilities $21.3M, shareholders' equity $40.6M, long-term debt $1.57M
What is OCGN's revenue?
OCUGEN INC reported $4.58M of revenue over its last four quarters, through June 30, 2026.
Is OCGN profitable?
No. OCUGEN INC lost $82.0M over the last four quarters.